These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 15635277

  • 1. Mizoribine pulse therapy for a pediatric patient with steroid-resistant nephrotic syndrome.
    Tanaka H, Tsugawa K, Nakahata T, Kudo M, Onuma S, Kimura S, Ito E.
    Tohoku J Exp Med; 2005 Jan; 205(1):87-91. PubMed ID: 15635277
    [Abstract] [Full Text] [Related]

  • 2. Long-term mizoribine intermittent pulse therapy for young patients with flare of lupus nephritis.
    Tanaka H, Tsugawa K, Suzuki K, Nakahata T, Ito E.
    Pediatr Nephrol; 2006 Jul; 21(7):962-6. PubMed ID: 16773408
    [Abstract] [Full Text] [Related]

  • 3. Mizoribine therapy combined with steroids and mizoribine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome.
    Saito T, Iwano M, Matsumoto K, Mitarai T, Yokoyama H, Yorioka N, Nishi S, Yoshimura A, Sato H, Ogahara S, Sasatomi Y, Kataoka Y, Ueda S, Koyama A, Maruyama S, Nangaku M, Imai E, Matsuo S, Tomino Y, Refractory Nephrotic Syndrome Study Group.
    Clin Exp Nephrol; 2017 Dec; 21(6):961-970. PubMed ID: 27783276
    [Abstract] [Full Text] [Related]

  • 4. Mizoribine for the treatment of lupus nephritis in children and adolescents.
    Tanaka H, Tsugawa K, Tsuruga K, Suzuki K, Nakahata T, Ito E, Waga S.
    Clin Nephrol; 2004 Dec; 62(6):412-7. PubMed ID: 15630899
    [Abstract] [Full Text] [Related]

  • 5. Implication of the peak serum level of mizoribine for control of the serum anti-dsDNA antibody titer in patients with lupus nephritis.
    Tanaka H, Tsugawa K, Nakahata T, Kudo M, Suzuki K, Ito E.
    Clin Nephrol; 2005 Jun; 63(6):417-22. PubMed ID: 15960142
    [Abstract] [Full Text] [Related]

  • 6. Effects of long-term treatment with mizoribine in patients with proliferative lupus nephritis.
    Yumura W, Suganuma S, Uchida K, Moriyama T, Otsubo S, Takei T, Naito M, Koike M, Nitta K, Nihei H.
    Clin Nephrol; 2005 Jul; 64(1):28-34. PubMed ID: 16047642
    [Abstract] [Full Text] [Related]

  • 7. A case of lupus nephritis improved after appropriately adjusting the dosage of mizoribine.
    Tsubouchi Y, Fukuda W, Kawahito Y, Kohno M, Wada M, Ishino H, Hamaguchi M, Yamamoto A, Kadoya M, Niimi M, Yoshikawa T.
    Mod Rheumatol; 2008 Jul; 18(1):91-5. PubMed ID: 18159569
    [Abstract] [Full Text] [Related]

  • 8. Mizoribine treatment of young patients with severe lupus nephritis: a clinicopathologic study by the tohoku pediatric study group.
    Tanaka H, Oki E, Tsuruga K, Sato N, Matsukura H, Matsunaga A, Kondo Y, Suzuki J.
    Nephron Clin Pract; 2008 Jul; 110(2):c73-9. PubMed ID: 18758186
    [Abstract] [Full Text] [Related]

  • 9. [Beneficial and adverse effects of high-dosage MZR therapy in the management of children with frequently relapsing nephrotic syndrome].
    Goto M, Ikeda M, Hataya H, Ishikura K, Hamasaki Y, Honda M.
    Nihon Jinzo Gakkai Shi; 2006 Jul; 48(4):365-70. PubMed ID: 16780106
    [Abstract] [Full Text] [Related]

  • 10. Oral mizoribine pulse therapy for patients with steroid-resistant and frequently relapsing steroid-dependent nephrotic syndrome.
    Kawasaki Y, Hosoya M, Kobayashi S, Ohara S, Onishi N, Takahashi A, Isome M, Suzuki H.
    Nephrol Dial Transplant; 2005 Oct; 20(10):2243-7. PubMed ID: 16030039
    [Abstract] [Full Text] [Related]

  • 11. High-dose mizoribine treatment for adolescents with systemic lupus erythematosus.
    Nozu K, Iijima K, Kamioka I, Fujita T, Yoshiya K, Tanaka R, Nakanishi K, Yoshikawa N, Matsuo M.
    Pediatr Int; 2006 Apr; 48(2):152-7. PubMed ID: 16635174
    [Abstract] [Full Text] [Related]

  • 12. Mizoribine oral pulse therapy for patients with disease flare of lupus nephritis.
    Tanaka H, Suzuki K, Nakahata T, Tsugawa K, Ito E, Waga S.
    Clin Nephrol; 2003 Dec; 60(6):390-4. PubMed ID: 14690255
    [Abstract] [Full Text] [Related]

  • 13. Mizoribine in steroid-dependent nephrotic syndrome of childhood.
    Hamasaki T, Mori M, Kinoshita Y, Saeki T, Sakano T.
    Pediatr Nephrol; 1997 Oct; 11(5):625-7. PubMed ID: 9323293
    [Abstract] [Full Text] [Related]

  • 14. Effect of single-dose oral mizoribine pulse therapy twice per week for frequently relapsing steroid-dependent nephrotic syndrome.
    Fujieda M, Ishihara M, Morita T, Hayashi A, Okada S, Ohta T, Sakano T, Wakiguchi H.
    Clin Nephrol; 2012 Jul; 78(1):40-6. PubMed ID: 22732336
    [Abstract] [Full Text] [Related]

  • 15. Single daily high-dose mizoribine therapy for children with steroid-dependent nephrotic syndrome prior to cyclosporine administration.
    Fujinaga S, Hirano D, Nishizaki N, Someya T, Ohtomo Y, Ohtsuka Y, Shimizu T, Kaneko K.
    Pediatr Nephrol; 2011 Mar; 26(3):479-83. PubMed ID: 21174219
    [Abstract] [Full Text] [Related]

  • 16. Assessment of factors associated with mizoribine responsiveness in children with steroid-dependent nephrotic syndrome.
    Kondoh T, Ikezumi Y, Yokoi K, Nakajima Y, Matsumoto Y, Kaneko M, Hasegawa H, Yamada T, Kumagai N, Ito T, Yoshikawa T.
    Clin Exp Nephrol; 2019 Sep; 23(9):1154-1160. PubMed ID: 31187341
    [Abstract] [Full Text] [Related]

  • 17. Long-term intermittent pulse therapy with mizoribine attenuates histologic progression in young patients with severe lupus nephritis: report of two patients.
    Tanaka H, Oki ES, Tsugawa K, Suzuki K, Tsuruga K, Ito E.
    Nephrology (Carlton); 2007 Aug; 12(4):376-9. PubMed ID: 17635753
    [Abstract] [Full Text] [Related]

  • 18. Mizoribine oral pulse therapy for steroid-dependent nephrotic syndrome.
    Kawasaki Y, Suzuki J, Takahashi A, Isome M, Nozawa R, Suzuki H.
    Pediatr Nephrol; 2005 Jan; 20(1):96-8. PubMed ID: 15503173
    [Abstract] [Full Text] [Related]

  • 19. Usefulness of mizoribine administration in children with frequently relapsing nephrotic syndrome, and the relationship between pharmacokinetic parameters and efficacy: a multicenter prospective cohort study in China.
    Xia ZK, Gao YF, Rong LP, Dang XQ, Shen Q, Jiang XY, Yi ZW, Xu H.
    World J Pediatr; 2019 Jun; 15(3):262-269. PubMed ID: 30864060
    [Abstract] [Full Text] [Related]

  • 20. Effect of oral mizoribine pulse therapy for frequently relapsing steroid-dependent nephrotic syndrome.
    Fujieda M, Ishihara M, Morita T, Hayashi A, Utsunomiya Y, Ohta T, Sakano T, Wakiguchi H.
    Clin Nephrol; 2008 Mar; 69(3):179-84. PubMed ID: 18397716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.